knowledge -WSS

knowledge

author：entertainment 2025-10-01 00:06:27 - browse：5596

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

WSS

Colorectal cancer study finds potential in overlooked immune cell

Bill would stop addiction treatment from triggering child abuse inquiry

Poland's lawmakers approve a divisive law on Russian influence

Doctors in states that ban abortion can still help patients

Sana to lay off nearly a third of staff, de

What AstraZeneca

Wikipedia

knowledge

hotspot

In age of alternative facts, a scholarly course on calling out crap

Trump team launching legal defense fund to help pay legal bills

At least 13 dead in Texas as scorching temps continue

Liquid biopsy for lung cancer is launched by Delfi

Hepatitis C has a cure — but many Americans still lack access to it

Bill would stop addiction treatment from triggering child abuse inquiry

In age of alternative facts, a scholarly course on calling out crap

Bill would stop addiction treatment from triggering child abuse inquiry

As demand for Covid shots wanes, Moderna seeks its next success

Physician executives need more than on

focus

Campaign finance charge dropped from case against Sam Bankman

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Phenylephrine and the overlooked value of the placebo effect

Trump team launching legal defense fund to help pay legal bills

HCA says smaller share of spending going to labor

A Q&A with the global head of Boehringer Ingelheim's innovation unit

knowledge

hotspot

focus

focus